Apellis Pharmaceuticals, Inc.

Direct answer

Apellis Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker APLS.

Apellis Pharmaceuticals, Inc. is an actively operating biopharmaceutical enterprise dedicated to the discovery, advancement, and commercialization of therapeutic agents. Its core strategy involves modulating the complement system to address various autoimmune and inflammatory conditions. The company's primary investigational compound, pegcetacoplan, is currently undergoing Phase III clinical evaluation. This...

Can you invest in Apellis Pharmaceuticals, Inc.?

Yes. Apellis Pharmaceuticals, Inc. trades publicly on NASDAQ as APLS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Apellis Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.